Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine
Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis worldwide and kills more Americans than 59 other infections, including HIV and tuberculosis, combined. While direct-acting antiviral (DAA) treatments are effective, limited uptake of therapy, particularly in high-risk groups,...
Үндсэн зохиолчид: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Бусад зохиолчид: | |
Формат: | Өгүүллэг |
Хэл сонгох: | English |
Хэвлэсэн: |
National Academy of Sciences
2020
|
Онлайн хандалт: | https://hdl.handle.net/1721.1/127652 |